View Financial HealthOrchasp 配当と自社株買い配当金 基準チェック /06Orchasp配当金を支払った記録がありません。主要情報n/a配当利回り6.5%バイバック利回り総株主利回り6.5%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026お知らせ • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).分析記事 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).お知らせ • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).お知らせ • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).お知らせ • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: ORCHASPの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: ORCHASPの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Orchasp 配当利回り対市場ORCHASP 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ORCHASP)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Software)2.8%アナリスト予想 (ORCHASP) (最長3年)n/a注目すべき配当: ORCHASPは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: ORCHASPは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: ORCHASPの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: ORCHASPが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/17 06:48終値2026/05/15 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Orchasp Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.
New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.
お知らせ • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026
お知らせ • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.
Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).
分析記事 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.
お知らせ • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025
New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).
お知らせ • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.
New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).
お知らせ • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025
Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).
お知らせ • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025
New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).
Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.